首页|非小细胞肺癌组织CXCL1、CXCL2表达与上皮间质转化及预后的关系研究

非小细胞肺癌组织CXCL1、CXCL2表达与上皮间质转化及预后的关系研究

扫码查看
目的:探讨非小细胞肺癌(NSCLC)组织C-X-C基序趋化因子配体(CXCL)1、CXCL2表达与上皮间质转化(EMT)及预后的关系。方法:选取行手术切除的NSCLC患者241例,检测NSCLC组织与癌旁组织(距NSCLC组织>3 cm)中CXCL1、CXCL2和EMT相关蛋白[波形蛋白(Vimentin)、蜗牛家族转录抑制因子1(SNAI1)、E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)]阳性表达率。比较NSCLC组织中CXCL1、CXCL2阳性表达在不同临床病理特征患者中的差异。随访3年,记录NSCLC患者总生存(OS)率,分析CXCL1、CXCL2阳性/阴性表达对NSCLC患者预后的影响。结果:与癌旁组织比较,NSCLC组织CXCL1、CXCL2、Vimentin、SNAI1、N-cadherin 阳性表达率升高,E-cadherin 阳性表达率降低(P<0。05)。NSCLC 组织 CXCL1、CXCL2 表达与 TNM分期、肿瘤直径、分化程度和淋巴结转移有关(P<0。05)。随访3年,241例NSCLC患者3年OS率为56。02%(135/241)。NSCLC患者中CXCL1、CXCL2阳性表达者3年OS率低于CXCL1、CXCL2阴性表达者(P<0。05)。结论:NSCLC组织CXCL1、CXCL2高表达,且与TNM分期、肿瘤直径、分化程度、淋巴结转移、EMT和预后有关。
Study on the Relationship between CXCL1,CXCL2 Expression and Epithelial Mesenchymal Transition and Prognosis in Non-Small Cell Lung Cancer Tissues
Objective:To investigate the relationship between the expression of C-X-C motif chemokine ligand(CXCL)1 and CXCL2 in non-small cell lung cancer(NSCLC)tissues and epithelial mesenchymal transition(EMT)and prognosis.Methods:241 NSCLC patients were selected,the positive expression rates of CXCL1,CXCL2 and EMT-related proteins[Vimentin(Vimentin),snail family transcription inhibitor 1(SNAI1),E-cadherin(E-cadherin),and N-cadherin(N-cadherin)]in NSCLC tissues and adjacent tissues(>3 cm from NSCLC tissue)were detected by immunohistochemistry.The correlation between CXCL1,CXCL2 expression and expression of EMT-related proteins in NSCLC tissues were analyzed.To compare the difference of CXCL1 and CXCL2 positive expression in NSCLC tissues in patients with different clinicopathological features.3 years after follow-up,the 3-year overall survival(OS)rate was recorded.Results:Compared with adjacent tissues,the positive expression rates of CXCL1,CXCL2,Vimentin,SNAI1 and N-cadherin in NSCLC tissues were increased,and the positive expression rate of E-cadherin was decreased(P<0.05).The expression of CXCL1 and CXCL2 in NSCLC tissues were related to TNM stage,tumor diameter,degree of differentiation and lymph node metastasis(P<0.05).Followed-up for 3 years,the 3-year OS rate of 241 NSCLC patients was 56.02%(135/241).The 3-year OS rate of CXCL1 and CXCL2 positive expression in NSCLC patients was lower than that of CXCL1 and CXCL2 negative expression.(P<0.05).The independent risk factors for death in NSCLC patients were TNM stage ⅢA,tumor diameter ≥ 3 cm,poor differentiation,CXCL1 positive,lymph node metastasis and CXCL2 positive(P<0.05).Conclusion:The high expression of CXCL1 and CXCL2 in NSCLC tissues are related to TNM stage,tumor diameter,degree of differentiation,lymph node metastasis,EMT and prognosis,which may become a new target for the diagnosis and treatment of NSCLC.

Non-small cell lung cancerC-X-C motif chemokine ligand 1C-X-C motif chemokine ligand 2Epithelial mesenchymal transitionPrognosis

顾海迪、杜玲玉、杨军、李辰、何贞月、谭洁、王晨洁

展开 >

南京医科大学附属苏州医院肿瘤内科 江苏苏州 215001

非小细胞肺癌 C-X-C基序趋化因子配体1 C-X-C基序趋化因子配体2 上皮间质转化 预后

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(21)